Page last updated: 2024-09-03

tyrosyl-prolyl-tryptophyl-glycinamide and guanosine 5'-o-(3-thiotriphosphate)

tyrosyl-prolyl-tryptophyl-glycinamide has been researched along with guanosine 5'-o-(3-thiotriphosphate) in 1 studies

Compound Research Comparison

Studies
(tyrosyl-prolyl-tryptophyl-glycinamide)
Trials
(tyrosyl-prolyl-tryptophyl-glycinamide)
Recent Studies (post-2010)
(tyrosyl-prolyl-tryptophyl-glycinamide)
Studies
(guanosine 5'-o-(3-thiotriphosphate))
Trials
(guanosine 5'-o-(3-thiotriphosphate))
Recent Studies (post-2010) (guanosine 5'-o-(3-thiotriphosphate))
25005,5428368

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harrison, LM; Kastin, AJ; Zadina, JE1

Other Studies

1 other study(ies) available for tyrosyl-prolyl-tryptophyl-glycinamide and guanosine 5'-o-(3-thiotriphosphate)

ArticleYear
Differential effects of endomorphin-1, endomorphin-2, and Tyr-W-MIF-1 on activation of G-proteins in SH-SY5Y human neuroblastoma membranes.
    Peptides, 1998, Volume: 19, Issue:4

    Topics: Cell Membrane; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; MSH Release-Inhibiting Hormone; Narcotic Antagonists; Neuroblastoma; Oligopeptides; Receptors, Opioid; Tumor Cells, Cultured

1998